A multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma
- 1 October 2003
- journal article
- abstracts
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 57 (2) , S194-S195
- https://doi.org/10.1016/s0360-3016(03)00994-5
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: